http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24847030

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 1182
issn 1744-8328
1473-7140
issueIdentifier 8
pageRange 1171-1182
publicationName Expert Review of Anticancer Therapy
startingPage 1171
bibliographicCitation Moreira C, Kaklamani V. Lapatinib and breast cancer: current indications and outlook for the future. Expert Rev Anticancer Ther. 2010 Aug;10(8):1171–82. doi: 10.1586/era.10.113. PMID: 20735304.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_843c05c71d5f7570c0171a64a15553ed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4beee70799472926d318ee5d2b1fbf77
date 201008
identifier https://pubmed.ncbi.nlm.nih.gov/20735304
https://doi.org/10.1586/era.10.113
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29775
https://portal.issn.org/resource/ISSN/1744-8328
https://portal.issn.org/resource/ISSN/1473-7140
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Lapatinib and breast cancer: current indications and outlook for the future
discusses http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0495206
http://id.nlm.nih.gov/mesh/M0473129
http://id.nlm.nih.gov/mesh/M0028048
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D011799Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000378
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000077341
http://id.nlm.nih.gov/mesh/D001943Q000201
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D002986Q000639
http://id.nlm.nih.gov/mesh/D047428Q000627
http://id.nlm.nih.gov/mesh/D018719Q000096
http://id.nlm.nih.gov/mesh/D005544
http://id.nlm.nih.gov/mesh/D011799Q000493
http://id.nlm.nih.gov/mesh/D047428Q000493
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136182740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626

Total number of triples: 58.